Skip to content

To evaluate the safety and efficacy of Yangyixing defocus lens for delaying the progression of myopia in children

To evaluate the safety and efficacy of Yangyixing defocus lens for delaying the progression of myopia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101121
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-25
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Experimental group:Yang Yixing defocus lens

Sponsors

Bejing Tongren Hospital, Capital Medical Uniersity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. The age ranged from 6 to 14 years, both sexes; 2. The refractive status met the following conditions: a) the spherical equivalent was between -0.50D and -6.00D (including -0.50D and -6.00D); b) astigmatism = 10mmHg, < 21mmHg); 4. Best corrected distance visual acuity of either eye better than or equal to 1.0; 5. There was no amblyopia or other ocular pathological changes in both eyes;

Exclusion criteria

Exclusion criteria: 1. One eye met the inclusion criteria; 2. There are any ocular or systemic diseases (such as congenital cataract, retinopathy of prematurity, Marfan syndrome, diabetes, etc.) that may be related to the development of myopia or affect the refractive state of the eye, or the medical treatment of the disease will affect the vision; 3. manifest strabismus or obvious binocular vision dysfunction; 4. Unwilling to cooperate with visitors; 5. other conditions for which the patient was deemed ineligible by the investigator;

Design outcomes

Primary

MeasureTime frame
Spherical equivalent mirror;Axial length of eye;Corrected vision;Best corrected visual acuity;

Countries

China

Contacts

Public ContactLei Tian

Bejing Tongren Hospital, Capital Medical Uniersity

tianlei0131@163.com+86 18600166885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026